GOSS
Price
$1.25
Change
-$0.05 (-3.85%)
Updated
Jun 27 closing price
Capitalization
284.13M
44 days until earnings call
TRVI
Price
$5.62
Change
-$0.04 (-0.71%)
Updated
Jun 27 closing price
Capitalization
683.04M
39 days until earnings call
Interact to see
Advertisement

GOSS vs TRVI

Header iconGOSS vs TRVI Comparison
Open Charts GOSS vs TRVIBanner chart's image
Gossamer Bio
Price$1.25
Change-$0.05 (-3.85%)
Volume$26.07M
Capitalization284.13M
Trevi Therapeutics
Price$5.62
Change-$0.04 (-0.71%)
Volume$2.23M
Capitalization683.04M
GOSS vs TRVI Comparison Chart in %
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. TRVI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a Buy and TRVI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (GOSS: $1.25 vs. TRVI: $5.62)
Brand notoriety: GOSS and TRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 1262% vs. TRVI: 124%
Market capitalization -- GOSS: $284.13M vs. TRVI: $684.26M
GOSS [@Biotechnology] is valued at $284.13M. TRVI’s [@Biotechnology] market capitalization is $684.26M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileTRVI’s FA Score has 0 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • TRVI’s FA Score: 0 green, 5 red.
According to our system of comparison, both GOSS and TRVI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 2 TA indicator(s) are bullish while TRVI’s TA Score has 1 bullish TA indicator(s).

  • GOSS’s TA Score: 2 bullish, 6 bearish.
  • TRVI’s TA Score: 1 bullish, 6 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than TRVI.

Price Growth

GOSS (@Biotechnology) experienced а -13.19% price change this week, while TRVI (@Biotechnology) price change was -5.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 12, 2025.

TRVI is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRVI($683M) has a higher market cap than GOSS($284M). GOSS (38.183) and TRVI (36.408) have similar YTD gains . GOSS has higher annual earnings (EBITDA): -35.7M vs. TRVI (-47.23M). GOSS has more cash in the bank: 258M vs. TRVI (103M). TRVI has less debt than GOSS: TRVI (957K) vs GOSS (203M). GOSS has higher revenues than TRVI: GOSS (125M) vs TRVI (0).
GOSSTRVIGOSS / TRVI
Capitalization284M683M42%
EBITDA-35.7M-47.23M76%
Gain YTD38.18336.408105%
P/E RatioN/AN/A-
Revenue125M0-
Total Cash258M103M250%
Total Debt203M957K21,212%
FUNDAMENTALS RATINGS
GOSS vs TRVI: Fundamental Ratings
GOSS
TRVI
OUTLOOK RATING
1..100
5362
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
4247
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRVI's Valuation (56) in the Pharmaceuticals Major industry is in the same range as GOSS (60). This means that TRVI’s stock grew similarly to GOSS’s over the last 12 months.

TRVI's Profit vs Risk Rating (73) in the Pharmaceuticals Major industry is in the same range as GOSS (100). This means that TRVI’s stock grew similarly to GOSS’s over the last 12 months.

TRVI's SMR Rating (97) in the Pharmaceuticals Major industry is in the same range as GOSS (100). This means that TRVI’s stock grew similarly to GOSS’s over the last 12 months.

GOSS's Price Growth Rating (42) in the Pharmaceuticals Major industry is in the same range as TRVI (47). This means that GOSS’s stock grew similarly to TRVI’s over the last 12 months.

GOSS's P/E Growth Rating (100) in the Pharmaceuticals Major industry is in the same range as TRVI (100). This means that GOSS’s stock grew similarly to TRVI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOSSTRVI
RSI
ODDS (%)
Bearish Trend 3 days ago
73%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
84%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HIZOF6.72N/A
N/A
KANADEVIA CORP.
CCLLF52.88N/A
N/A
CCL Industries Inc.
ECAOF0.14N/A
N/A
Eco Atlantic Oil & Gas Ltd
NTTDF24.82N/A
N/A
NTT DATA GROUP CORPORATION
ABCP0.32N/A
-0.69%
AmBase Corp.

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with VIR. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then VIR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
-3.85%
VIR - GOSS
41%
Loosely correlated
-2.64%
RARE - GOSS
36%
Loosely correlated
-2.43%
PDSB - GOSS
35%
Loosely correlated
-2.76%
IONS - GOSS
35%
Loosely correlated
N/A
ABEO - GOSS
35%
Loosely correlated
-2.54%
More

TRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRVI has been loosely correlated with PTGX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TRVI jumps, then PTGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRVI
1D Price
Change %
TRVI100%
-0.71%
PTGX - TRVI
44%
Loosely correlated
+0.86%
BIESF - TRVI
42%
Loosely correlated
N/A
MLYS - TRVI
31%
Poorly correlated
-2.07%
GOSS - TRVI
29%
Poorly correlated
-3.85%
XENE - TRVI
28%
Poorly correlated
+0.62%
More